Bai H, Saku K, Liu R, Imamura M, Arakawa K
Department of Internal Medicine, Fukuoka University School of Medicine, Japan.
Hum Genet. 1995 Jan;95(1):102-4. doi: 10.1007/BF00225084.
Several studies have reported that a variant allele (S2) of the apolipoprotein (apo) A-I/C-III/A-IV complex is associated with hyperlipoproteinemia in some populations and that the frequency of this allele is two- to fivefold higher in patients with premature coronary heart disease (CHD) than in healthy controls. In the present study in a Japanese population, we were unable to confirm the association of the S2 allele with either coronary heart disease or elevated serum apo C-III levels, as has been previously reported in Caucasians. No genotype difference was observed among the severity of coronary heart disease, as determined by the number of involved vessels (one, two and three vessel disease), compared to controls. In addition, the frequency of the S2 allele among Japanese, in both CHD (0.328) and controls (0.369), was quite different from that in many other populations.
几项研究报告称,载脂蛋白(apo)A-I/C-III/A-IV复合物的一个变异等位基因(S2)在一些人群中与高脂蛋白血症相关,并且该等位基因在早发冠心病(CHD)患者中的频率比健康对照者高两到五倍。在本次针对日本人群的研究中,我们无法证实S2等位基因与冠心病或血清载脂蛋白C-III水平升高之间的关联,而此前在高加索人群中曾有过相关报道。与对照组相比,根据受累血管数量(单支、双支和三支血管病变)确定的冠心病严重程度之间未观察到基因型差异。此外,日本人群中CHD患者(0.328)和对照组(0.369)中S2等位基因的频率与许多其他人群有很大差异。